Computational identification of human ubiquitination sites using convolutional and recurrent neural networks.


Journal

Molecular omics
ISSN: 2515-4184
Titre abrégé: Mol Omics
Pays: England
ID NLM: 101713384

Informations de publication

Date de publication:
06 12 2021
Historique:
pubmed: 14 9 2021
medline: 29 1 2022
entrez: 13 9 2021
Statut: epublish

Résumé

Ubiquitination is a very important protein post-translational modification in humans, which is closely related to many human diseases such as cancers. Although some methods have been elegantly proposed to predict human ubiquitination sites, the accuracy of these methods is generally not very satisfactory. In order to improve the prediction accuracy of human ubiquitination sites, we propose a new ensemble method HUbipPred, which takes the binary encoding and physicochemical properties of amino acids as training features, and integrates two intensively trained convolutional neural networks and two recurrent neural networks to build the model. Finally, HUbiPred achieves AUC values of 0.852 and 0.844 in five-fold cross-validation and independent tests, respectively, which greatly improves the prediction accuracy compared to previous predictors. We also analyze the physicochemical properties of amino acids around ubiquitination sites, study the important roles of architectures (

Identifiants

pubmed: 34515266
doi: 10.1039/d0mo00183j
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

948-955

Auteurs

Xiaofeng Wang (X)

College of Mathematics and Computer Sciences, Shanxi Normal University, Linfen 041004, China. wangxf@sxnu.edu.cn.

Renxiang Yan (R)

School of Biological Sciences and Engineering, Fujian Key Laboratory of Marine Enzyme Engineering, Fuzhou University, Fuzhou 350002, China. yanrenxiang@fzu.edu.cn.

Yongji Wang (Y)

College of Life Sciences, Shanxi Normal University, Linfen 041000, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH